Solana Company has applied to the British Columbia Securities Commission and the Ontario Securities Commission to cease being a reporting issuer in Canadian Jurisdictions. If granted, the Company will no longer file financial statements in Canada but will continue to comply with U.S. securities laws and Nasdaq rules. Forward-looking statements caution potential differences in actual results. Solana Company is a neurotech medical device company and digital asset treasury, aiming to enhance brain function and promote neuroplasticity. For more information, visit www.solanacompany.co.

Read more at GlobeNewswire: Solana Company Files Application to Cease to Be a Reporting